UDHCF - Udg Healthcare Stock Price, News & Analysis

$12.65 0.00 (0.00 %)
(As of 11/22/2017 04:00 PM ET)
Previous Close$12.65
Today's Range$12.65 - $12.65
52-Week Range$8.01 - $12.65
VolumeN/A
Average Volume606 shs
Market Capitalization$3.14 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Udg Healthcare (OTCMKTS:UDHCF)

Udg Healthcare logo


Industry, Sector and Symbol:
  • Industry: N/A
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: OTCMKTS:UDHCF
  • CUSIP: N/A
  • Web: www.udghealthcare.com
Price-To-Earnings:
  • Forward P/E Ratio: 35.15
  • P/E Growth: 2.8
Sales & Book Value:
  • Annual Sales: $1.05 billion
  • Price / Sales: 3.00
  • Book Value: N/A
  • Price / Book: N/A
Misc:
  • Outstanding Shares: 248,260,000
 

Frequently Asked Questions for Udg Healthcare (OTCMKTS:UDHCF)

What is Udg Healthcare's stock symbol?

Udg Healthcare trades on the OTCMKTS under the ticker symbol "UDHCF."

When will Udg Healthcare make its next earnings announcement?

Udg Healthcare is scheduled to release their next quarterly earnings announcement on Friday, December, 15th 2017. View Earnings Estimates for Udg Healthcare.

Who are some of Udg Healthcare's key competitors?

How do I buy Udg Healthcare stock?

Shares of Udg Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Udg Healthcare's stock price today?

One share of Udg Healthcare stock can currently be purchased for approximately $12.65.

How big of a company is Udg Healthcare?

Udg Healthcare has a market capitalization of $3.14 billion and generates $1.05 billion in revenue each year.

How can I contact Udg Healthcare?

Udg Healthcare's mailing address is United Drug House Magna Drive Magna Business Park Citywest Road, Dublin L2, 24. The company can be reached via phone at 353-1463-2300 or via email at [email protected]


MarketBeat Community Rating for Udg Healthcare (UDHCF)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about Udg Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Udg Healthcare (OTCMKTS:UDHCF)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Udg Healthcare (OTCMKTS:UDHCF)

Price Target History for Udg Healthcare (OTCMKTS:UDHCF)

Analysts' Ratings History for Udg Healthcare (OTCMKTS:UDHCF)

Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Udg Healthcare (OTCMKTS:UDHCF)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Udg Healthcare (OTCMKTS:UDHCF)
Current Year EPS Consensus Estimate: $0.36 EPS
Next Year EPS Consensus Estimate: $0.44 EPS

Dividends

Dividend History for Udg Healthcare (OTCMKTS:UDHCF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Udg Healthcare (OTCMKTS UDHCF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Udg Healthcare (OTCMKTS UDHCF)

Source:
No headlines for this company have been tracked by MarketBeat.com

Social Media

Financials

Financials are not available for this stock.

Chart

Udg Healthcare (OTCMKTS UDHCF) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.